Syneos Health to Present at Upcoming Investor Conferences

Rhea-AI Summary

Syneos Health (Nasdaq:SYNH) announced its participation in two key investor conferences. CEO Michelle Keefe and CFO Jason Meggs will present at the 42nd Annual William Blair Growth Stock Conference in Chicago on June 6, 2022, at 3:20 p.m. CT and the Jefferies Healthcare Conference in New York on June 8, 2022, at 3:30 p.m. ET. Both events will feature live webcasts accessible through the Company’s Investor Relations website. Syneos Health is a fully integrated biopharmaceutical solutions organization dedicated to advancing customer success.

MORRISVILLE, N.C., May 24, 2022 (GLOBE NEWSWIRE) -- Syneos Health^® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced that the Company is scheduled to present at two upcoming investor conferences. Chief Executive Officer Michelle Keefe and Chief Financial Officer Jason Meggs are scheduled to present at the following conferences:

• 42^nd Annual William Blair Growth Stock Conference in Chicago, IL, on Monday, June 6, 2022, at 3:20 p.m. CT
• Jefferies Healthcare Conference in New York, NY, on Wednesday, June 8^th, 2022, at 3:30 p.m. ET

A live webcast of each event, along with a link to the presentation materials and archived replay of each presentation, will be available on the Company’s Investor Relations website at investor.syneoshealth.com.

About Syneos Health

Syneos Health^® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, strategically blending clinical development, medical affairs and commercial capabilities to address modern market realities.

We bring together approximately 29,000 minds, across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.

Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

To learn more about how we are Shortening the distance from lab to life^®, visit syneoshealth.com or subscribe to our podcast.

Investor Relations Contact:	Press/Media Contact:
Ronnie Speight	Gary Gatyas
Senior Vice President, Investor Relations	Executive Director, External Communications
+1 919 745 2745	+1 908 763 3428
Investor.Relations@syneoshealth.com	gary.gatyas@syneoshealth.com

FAQ

What is the schedule for Syneos Health's presentations at investor conferences in June 2022?

Syneos Health will present at the William Blair Growth Stock Conference on June 6, 2022, at 3:20 p.m. CT and at the Jefferies Healthcare Conference on June 8, 2022, at 3:30 p.m. ET.

Where can I view the live webcast of Syneos Health's investor presentations?

You can view the live webcast of Syneos Health's presentations on their Investor Relations website at investor.syneoshealth.com.

Who will represent Syneos Health at the upcoming investor conferences?

Syneos Health will be represented by CEO Michelle Keefe and CFO Jason Meggs at the investor conferences.

What is the focus of Syneos Health as a biopharmaceutical organization?

Syneos Health is focused on providing integrated solutions to accelerate customer success within the biopharmaceutical industry.

How many employees does Syneos Health have globally?

Syneos Health has approximately 29,000 employees across more than 110 countries.